Preparation and Characterization of Tablet Formulation based on Solid Dispersion of Glimepiride and Poly(ester amide) Hyperbranched Polymer

References

• Serajuddin AT. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 1999;88:1058–1066.
   PubMed Web of Science ®Google Scholar
• Fahr A, Liu X. Drug delivery strategies for poorly water-soluble drugs. Expert Opin Drug Deliv 2007;4:403–416.
   PubMed Web of Science ®Google Scholar
• Malpani A, Rao SDK, Manoj DS. Promising novel approaches for oral delivery of poorly soluble drugs. An International journal of advances in pharmaceutical sciences. Pharm Rev 2009;7.
   Google Scholar
• Fujii M, Okada H, Shibata Y, Teramachi H, Kondoh M, Watanabe Y. Preparation, characterization, and tableting of a solid dispersion of indomethacin with crospovidone. Int J Pharm 2005;293:145–153.
   PubMed Web of Science ®Google Scholar
• Shavi VG, Kumar AR, Usha YN, Armugam K, Ranjan OP, Ginjupalli K, Pandey S, Udupa N. Enhanced dissolution and bioavailaibility of gliclazide using solid dispersion techniques. Int J Drug Deliv. 2010;2:49–57.
   Google Scholar
• Leonardi D, Barrera MG, Lamas MC, Salomón CJ. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters. AAPS PharmSciTech 2007;8:E108.
   Google Scholar
• Pathak D, Dahiya S, Pathak K. Solid dispersion of meloxicam: factorially designed dosage form for geriatric population. Acta Pharm 2008;58:99–110.
   PubMed Web of Science ®Google Scholar
• Kalava BS, Demirel M, Yazan Y. Physicochemical characterization and dissolution properties of cinnarizine solid dispersions. Turkish J Pharm Sci. 2005;2:51–62.
   Google Scholar
• Dhirendra K, Lewis S, Udupa N, Atin K. Solid dispersions: a review. Pak J Pharm Sci 2009;22:234–246.
   PubMed Web of Science ®Google Scholar
• Karanth H, Shenoy VS, Murthy RR. Industrially feasible alternative approaches in the manufacture of solid dispersions: a technical report. AAPS PharmSciTech 2006;7:87.
   PubMedGoogle Scholar
• Craig DQ. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm 2002;231:131–144.
   PubMed Web of Science ®Google Scholar
• Nazzal S, Guven N, Reddy IK, Khan MA. Preparation and characterization of coenzyme Q10-Eudragit solid dispersion. Drug Dev Ind Pharm 2002;28:49–57.
   PubMed Web of Science ®Google Scholar
• Thybo P, Pedersen BL, Hovgaard L, Holm R, Mullertz A. Characterization and physical stability of spray dried solid dispersions of probucol and PVP-K30. Pharm Dev Technol 2008;13:375–386.
   PubMed Web of Science ®Google Scholar
• Thybo P, Kristensen J, Hovgaard L. Characterization and physical stability of tolfenamic acid-PVP K30 solid dispersions. Pharm Dev Technol 2007;12:43–53.
   PubMed Web of Science ®Google Scholar
• Chaulang G, Patel P, Hardikar S, Kelhar M, Bhosale A, Bhise S. Formulation and evaluation of solid dispersions of furosemide in sodium starch glycollate. Trop J Pharm Res. 2009;8:43–51.
   Web of Science ®Google Scholar
• Chaulang G, Patil K, Ghodke D, Khan S, Yeole P. Preparation and characterization of solid dispersion tablet of furosemide with crosspovidone. Research J Pharm and Techn. 2009;1:386–389.
   Google Scholar
• Goračinova K, Klisarova L, Simov A, Fredro-Kumbaradži E, Mladenovska K, Glavaš M. Drug dissolution profiles and physico-chemical stability of controlled-release solid dispersion granules. Bull Chem Technol Macedonia. 1998;17:33–39.
   Google Scholar
• Khan MA, Karnachi AA, Agarwal V, Vaithiyalingam SR, Nazzal S, Reddy IK. Stability characterization of controlled release coprecipitates and solid dispersions. J Control Release 2000;63:1–6.
   PubMed Web of Science ®Google Scholar
• Tong P, Zografi G. Effects of water vapor absorption on the physical and chemical stability of amorphous sodium indomethacin. AAPS PharmSciTech. 2005;5:1–8.
   Google Scholar
• Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 1997;86:1–12.
   PubMed Web of Science ®Google Scholar
• Reven S, Grdadolnik J, Kristl J, Zagar E. Hyperbranched poly(esteramides) as solubility enhancers for poorly water-soluble drug glimepiride. Int J Pharm 2010;396:119–126.
   PubMed Web of Science ®Google Scholar
• Duncan R, Izzo L. Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 2005;57:2215–2237.
   PubMed Web of Science ®Google Scholar
• Žagar E, Žigon M. Aliphatic Hyperbranched Polyesters Based on 2,2-Bis(methylol)propionic Acid− Determination of Structure, Solution and Bulk Properties. Progress in Polymer Science. 2010. doi:10.1016/j.progpolymsci.2010.08.004.
   Google Scholar
• Cruz Silva MM, Madeira VM, Almeida LM, Custódio JB. Hydroxytamoxifen interaction with human erythrocyte membrane and induction of permeabilization and subsequent hemolysis. Toxicol In Vitro 2001;15:615–622.
   PubMedGoogle Scholar
• Uniformity of mass of single-dose preparations (2.9.5). 2008. European Pharmacopoeia 6.0. 278.
   Google Scholar
• Tang XC, Pikal MJ, Taylor LS. The effect of temperature on hydrogen bonding in crystalline and amorphous phases in dihydropyrine calcium channel blockers. Pharm Res 2002;19:484–490.
   PubMed Web of Science ®Google Scholar
• Dhumal RS, Biradar SV, Aher S, Paradkar AR. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability. J Pharm Pharmacol 2009;61:743–751.
   PubMed Web of Science ®Google Scholar
• Cruz Silva MM, Madeira VM, Almeida LM, Custódio JB. Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure. Biochim Biophys Acta 2000;1464:49–61.
   PubMed Web of Science ®Google Scholar
• Lieber MR, Lange Y, Weinstein RS, Steck TL. Interaction of chlorpromazine with the human erythrocyte membrane. J Biol Chem 1984;259:9225–9234.
   PubMed Web of Science ®Google Scholar